33 - ANÁLISIS DE LOS TRATAMIENTOS SUBSIGUIENTES ANTINEOPLÁSICOS DEL ESTUDIO DE FASE 3 HIMALAYA: TREMELIMUMAB MÁS DURVALUMAB EN EL CARCINOMA HEPATOCELULAR AVANZADO O IRRESECABLE
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Publication details
- Journal / source
- Gastroenterología y Hepatología
- Volume
- 49
- Pages
- 113244–113244
- Publication date
- 1 February 2026
- Language
- EN